NTRB
Nutriband Inc
NASDAQ · Pharmaceuticals
$4.35
+0.01 (+0.12%)
Open$4.30
Previous Close$4.35
Day High$4.50
Day Low$4.30
52W High$44.36
52W Low$21.49
Volume—
Avg Volume448.1K
Market Cap52.96M
P/E Ratio20.46
EPS$1.62
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+693.3% upside
Current
$4.35
$4.35
Target
$34.51
$34.51
$26.32
$34.51 avg
$56.88
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 21.09M | 21.69M | 16.36M |
| Net Income | 2.64M | 2.61M | 1.89M |
| Profit Margin | 12.5% | 12.0% | 11.5% |
| EBITDA | 4.33M | 4.63M | 3.66M |
| Free Cash Flow | 3.40M | 2.95M | 1.96M |
| Rev Growth | -6.9% | +19.5% | +23.4% |
| Debt/Equity | 0.58 | 0.66 | 0.65 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |